AKT1 and central nervous system cancer: Bergamin et al. [126] found that UA at 15–20 μM increased the number of C6 glioma cells in sub-G1 phase, induced apoptotic cell death and also reduced the expression level and activity of protein kinase B (Akt) in vitro.